Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 3626 3683 3684
This examiner grants 21% of resolved cases
Rachel L. Porter is an examiner in Tech Center 3600, Art Unit 3626, with 424 resolved cases. She has a low allowance rate of 21.2 percent, which indicates a challenging environment for applicants. The median time to allowance is 1786 days, reflecting a very long prosecution process. This duration suggests that the path to a grant is both difficult and time-consuming.
The interview lift for this examiner is 23.9 percent. This is a very high lift relative to the 21.2 percent allowance rate, suggesting that an interview is almost essential for success. Practitioners should be prepared for a long-term commitment, as shown by the 1786-day median pendency. With 424 resolved cases, the examiner's data shows a consistent pattern of high scrutiny. An interview may be the best way to overcome rejections and improve the low probability of allowance in Art Unit 3626 within Tech Center 3600.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17621976 | Providing Guidance During A Medical Procedure | Non-Final OA | Stryker Corporation |
| 18489171 | MEDICAL DIAGNOSIS SUPPORT DEVICE, MEDICAL DIAGNOSIS SUPPORT METHOD, AND STORAGE MEDIUM | Non-Final OA | Canon Kabushiki Kaisha |
| 16760792 | CLINICAL DECISION SUPPORT | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 16724893 | METHOD AND SYSTEM FOR DETECTING AN OPERATION STATUS FOR A SENSOR | Non-Final OA | Roche Diabetes Care, Inc. |
| 19298345 | SYSTEM AND METHOD FOR CLINICAL TRIALS | Non-Final OA | Muehlhausen Limited |
| 19294615 | Dabigatran Dosing | Non-Final OA | Closed Loop Medicine Ltd |
| 18858801 | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM | Non-Final OA | MITSUBISHI TANABE PHARMA CORPORATION |
| 17095179 | ARCHIVING RADIATION THERAPY RECORDS FOR TRANSMISSION AND REVIEW | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18706169 | A METHOD AND SYSTEM FOR DETERMINING A RISK OF AN ONSET OR PROGRESSION OF MYOPIA | Non-Final OA | Essilor International |
| 18773302 | APPARATUS AND METHOD FOR DETERMINING WOMENS HEALTH ATTRIBUTES IN FEMALE CLASSIFICATION TIME-SERIES DATA | Final Rejection | Anumana, Inc. |
| 18878829 | SYSTEM AND METHOD FOR PROVIDING A TRUE HEALTH-WELLNESS STATUS OF A USER | Final Rejection | Girish KRISHNAMURTHY |
| 18972457 | METHODS AND SYSTEMS FOR DETECTING PRESCRIPTION ANOMALIES IN REAL TIME | Non-Final OA | DRFIRST.COM, INC. |
| 18361046 | ELECTRONIC CLINICAL TRIAL PROTOCOL MANAGEMENT SYSTEMS AND RELATED METHODS | Final Rejection | Flatiron Health, Inc. |
| 18143755 | A/B TESTING AND RANDOM CLINICAL TRIALS IN LEARNING MANAGEMENT SYSTEMS | Non-Final OA | Western Governors University |
| 18016025 | SECURE, AUTOMATED, SYSTEM AND COMPUTER IMPLEMENTED PROCESS FOR MONITORING CARE PROVIDED TO A CONSUMER ACCORDING TO A PHARMACOLOGICAL OR NUTRITIONAL REGIMEN OF THE CONSUMER | Non-Final OA | Blunergy S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy